Search Results - Martinez Quetglas, Iris

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity

    Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity by Moeini, Agrin, Sia, Daniela, Zhang, Zhongyang, Camprecios, Genis, Stueck, Ashley, Dong, Hui, Montal, Robert, Torrens, Laura, Martinez-Quetglas, Iris, Fiel, M. Isabel, Hao, Ke, Villanueva, Augusto, Thung, Swan N, Schwartz, Myron E, Llovet, Josep M

    Published in Journal of hepatology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC

    Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC by Piqué-Gili, Marta, Andreu-Oller, Carmen, Mesropian, Agavni, Esteban-Fabró, Roger, Bárcena-Varela, Marina, Ruiz de Galarreta, Marina, Montironi, Carla, Martinez-Quetglas, Iris, Cappuyns, Sarah, Peix, Judit, Keraite, Ieva, Gris-Oliver, Albert, Fernández-Martínez, Elisa, Mauro, Ezequiel, Torres-Martin, Miguel, Abril-Fornaguera, Jordi, Lindblad, Katherine E., Lambrechts, Diether, Dekervel, Jeroen, Thung, Swan N., Sia, Daniela, Lujambio, Amaia, Pinyol, Roser, Llovet, Josep M.

    Published in JHEP reports
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    BP43131, a Phase 1 Dose Escalation Study: CD19 Targeted CD28 Costimulatory Agonist (RO7443904) Combined with Glofitamab Shows Promising Efficacy in Patients with Relapsed/Refractory Aggressive B-NHL

    BP43131, a Phase 1 Dose Escalation Study: CD19 Targeted CD28 Costimulatory Agonist (RO7443904) Combined with Glofitamab Shows Promising Efficacy in Patients with Relapsed/Refractor... by Dickinson, Michael J., Hutchings, Martin, Morschhauser, Franck, Carlo-Stella, Carmelo, Falchi, Lorenzo, Caimi, Paolo F., Dimier, Natalie, Smith, Lance, Whayman, Matt, Sam, Johannes, Keelara, Abiraj, Korfi, Koorosh, Jamois, Candice, Gallien, Jeremy, Martin, Nicole, Martinez Quetglas, Iris, Hinton, Heather, Prieto, Isabel, Michielin, Francesca, Lechner, Katharina, Gritti, Giuseppe

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 3820: Epigenetic re-expression of fetal IGF2 as therapeutic target in hepatocellular carcinoma

    Abstract 3820: Epigenetic re-expression of fetal IGF2 as therapeutic target in hepatocellular carcinoma by Martinez-Quetglas, Iris, Pinyol, Roser, Dauch, Daniel, Torrecilla, Sara, Tovar, Victoria, Moeini, Agrin, Alsinet, Clara, Portela, Anna, Villanueva, Augusto, Esteller, Manel, Zender, Lars, Llovet, Josep M

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Which peritransplant features can predict graft survival in donor after circulatory death kidney transplantation?

    Which peritransplant features can predict graft survival in donor after circulatory death kidney transplantation? by Coello, Iris, Martínez, Ana Isabel, Peraire, Maria, Aizpiri, Laura, Vega, Camila Andrea, Amer, Miquel, Guldris, Ricardo José, Bauzà Quetglas, José L., Carmelo Pieras, Enrique

    Published in Nefrología
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    Qué factores peritrasplante pueden predecir la supervivencia del injerto en el trasplante renal de donante en asistolia?

    Qué factores peritrasplante pueden predecir la supervivencia del injerto en el trasplante renal de donante en asistolia? by Coello, Iris, Martínez, Ana Isabel, Peraire, Maria, Aizpiri, Laura, Vega, Camila Andrea, Amer, Miquel, Guldris, Ricardo José, Quetglas, José L Bauzà, Pieras, Enrique Carmelo

    Published in Nefrología
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: